CTOs on the Move

Ocular Therapeutix

www.ocutx.com

 
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ocutx.com
  • 34 Crosby Drive Ste 105
    Bedford, MA USA 01730
  • Phone: 781.357.4000

Executives

Name Title Contact Details
Steve Fedan
Director of Information Technology Profile

Funding

Ocular Therapeutix raised $35.1M on 01/30/2018

Similar Companies

Erweka America Corp

Erweka America Corp is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meinhard Glass Products

Meinhard Glass Products is a Golden, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medical supply net

medical supply net is a San Dimas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.

Novera Drugs

Novera Drugs is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.